RET Fusion as a Novel Driver of Medullary Thyroid Carcinoma

INTRODUCTION: Oncogenic RET tyrosine kinase gene fusions and activating mutations have recently been identified in lung cancers, prompting initiation of targeted therapy trials in this disease. Although RET point mutation has been identified as a driver of tumorigenesis in medullary thyroid carcinom...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Endocrinol Metab
Main Authors: Grubbs, Elizabeth G., Ng, Patrick Kwok-Shing, Bui, Jacquelin, Busaidy, Naifa L., Chen, Ken, Lee, Jeffrey E., Lu, Xinyan, Lu, Hengyu, Meric-Bernstam, Funda, Mills, Gordon B., Palmer, Gary, Perrier, Nancy D., Scott, Kenneth L., Shaw, Kenna R., Waguespack, Steven G., Williams, Michelle D., Yelensky, Roman, Cote, Gilbert J.
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrine Society 2015
Assuntos:
Special Features
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4333032/
https://ncbi.nlm.nih.gov/pubmed/25546157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-4153
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados